Cause of death, by non-communicable diseases, ages 5-14, female in Latvia
Latvia: Cause of death, by non-communicable diseases, ages 5-14, female was 49.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in Latvia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14, female in Latvia is 49.5%, measured in 2021.
Compared with earlier readings it is down 11.1% on the previous year and up 19.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Latvia peaked at 55.7% in 2020 and was at its lowest, 41.3%, in 2010.
Latvia ranks 63rd of 184 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14, female in Latvia, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 47.1% | — |
| 2010 | 41.3% | -12.2% |
| 2015 | 52.8% | +27.8% |
| 2019 | 47.9% | -9.4% |
| 2020 | 55.7% | +16.3% |
| 2021 | 49.5% | -11.1% |
Latvia compared with similar countries
- Latvia's 49.5% is below the median for high income countries, which is 61.7%, 80% of the median. (57 countries reporting)
- Latvia's 49.5% is below the median for Europe & Central Asia, which is 60.6%, 82% of the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 47.1% | 47.1% | 47.1% | 1 |
| 2010s | 47.3% | 41.3% | 52.8% | 3 |
| 2020s | 52.6% | 49.5% | 55.7% | 2 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Latvia?
- Cause of death, by non-communicable diseases, ages 5-14, female in Latvia was 49.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Latvia?
- The highest recorded value was 55.7% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Latvia?
- The lowest recorded value was 41.3% in 2010.
- How does Latvia rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Latvia ranks 63rd out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Latvia?
- Over the last ten years it is up 19.8%. The long-run trend across the full record is rising.
- Where does this Latvia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.